Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.
The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...
Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...
News Medical on MSN1d
Research Reveals Top Treatment for High-Risk Pulmonary EmbolismA current study involving the University Hospital Bonn (UKB) has investigated which treatment strategy offers the best ...
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
A recent study found that participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback